Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer
ConclusionsCompared to the weekly chemotherapy regimens with the standard dose, our study demonstrated similar PFS, but a prolonged OS with the EP regimen. The clinical response rate of weekly regimens was better than the full-dose regimen. Adverse events and toxicity rates were different and depended on the type of chemotherapy regimen used.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Anaphylactic Shock | Anemia | Brain | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Hematology | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Statistics | Study | Taxotere | Toxicology